Paula Whitehead
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Paula Whitehead has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Andrew J. McLachlan
Sydney Pharmacy School, Faculty of Medicine and Health University of Sydney Sydney New South Wales Australia
1 shared publication - J. Simon Bell
Faculty of Pharmacy, The University of Sydney, New South Wales, Australia
1 shared publication - Parisa Aslani
The University of Sydney
1 shared publication - Timothy Frank Chen
School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia
1 shared publication
Latest Publications
- Open Access
- 7 December 2005
- Published by Springer Nature in Australia and New Zealand Health Policy
- Vol. 2 (1) , 29
Community pharmacy services to optimise the use of medications for mental illness: a systematic review
The objective of this systematic review was to evaluate the impact of pharmacist delivered community-based services to optimise the use of medications for mental illness. Twenty-two controlled (randomised and non-randomised) studies of pharmacists' interventions in community and residential aged care settings identified in international scientific literature were included for review. Papers were assessed for study design, service recipient, country of origin, intervention type, number of participating pharmacists, methodological quality and outcome measurement. Three studies showed that pharmacists' medication counselling and treatment monitoring can improve adherence to antidepressant medications among those commencing treatment when calculated using an intention-to-treat analysis. Four trials demonstrated that pharmacist conducted medication reviews may reduce the number of potentially inappropriate medications prescribed to those at high risk of medication misadventure. The results of this review provide some evidence that pharmacists can contribute to optimising the use of medications for mental illness in the community setting. However, more well designed studies are needed to assess the impact of pharmacists as members of community mental health teams and as providers of comprehensive medicines information to people with schizophrenia and bipolar disorder
- 7 December 2005
- Published by Springer Nature in Australia and New Zealand Health Policy
- Vol. 2 (1) , 29
Open AccessCommunity pharmacy services to optimise the use of medications for mental illness: a systematic review
The objective of this systematic review was to evaluate the impact of pharmacist delivered community-based services to optimise the use of medications for mental illness. Twenty-two controlled (randomised and non-randomised) studies of pharmacists' interventions in community and residential aged care settings identified in international scientific literature were included for review. Papers were assessed for study design, service recipient, country of origin, intervention type, number of participating pharmacists, methodological quality and outcome measurement. Three studies showed that pharmacists' medication counselling and treatment monitoring can improve adherence to antidepressant medications among those commencing treatment when calculated using an intention-to-treat analysis. Four trials demonstrated that pharmacist conducted medication reviews may reduce the number of potentially inappropriate medications prescribed to those at high risk of medication misadventure. The results of this review provide some evidence that pharmacists can contribute to optimising the use of medications for mental illness in the community setting. However, more well designed studies are needed to assess the impact of pharmacists as members of community mental health teams and as providers of comprehensive medicines information to people with schizophrenia and bipolar disorder